Campbell Adrenal Disorders 2021 Flashcards

1
Q

Cells of this tissue zone are the sole source of aldosterone

A

Zona glomerulosa

** Aldosterone regulates electrolyte metabolism by stimulating epithelial cells of the distal nephron to reabsorb Na+ and Cl−, while secreting H+ and K+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Site of glucocorticoid production.

Expression of enzymes: 17alpha-hydroxylase, 21-hydroxylase, and 11beta-hydroxylase.

A

Zona fasciculata

** Cortisol: primary glucocorticoid in humans, controlled by ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Production of DHEA, sulfated DHEAS, and androstenedione

A

Zona reticularis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lies at the center of the adrenal;
Integral part of the autonomic nervous system;
Secretes catecholamines;
Source of metanephrine and normetanephrine

A

Adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Catalyzes conversion of NE to epineprhine

Expressed in the adrenal medulla, brain, and organ of Zuckerkandl

A

Phenyethanolamine-N-methyltransferase (PNMT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypercortisolism secondary to excessive production of glucocorticoids by the adrenal cortex.

A

Cushing syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Three main groups of causes of Cushing syndrome

A

Exogenous: iatrogenic glucocorticoid administration

ACTH dependent: elevated serum corticotropin level by pathology extrinsic to adrenal (85% of Cushing syndrome)

ACTH independent: unregulated overproduction of glucocorticoids by the adrenal (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most common cause of hypercortisolism in the West.

A

Exogenous Cushing syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

85% of endogenous Cushing syndrome
Majority: primary pituitary pathology
Other causes: Ectopic ACTH production, ectopic CRH production

A

ACTH dependent Cushing Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cushing Syndrome vs. Cushing Disease vs. Cushing Triad

A

Syndrome: Hypercortisolism secondary to excessive production of glucocorticoids

Disease: hypercortisolism through excessive secretion of ACTH by the pituitary gland/macroadenoma

Triad: triad of elevated intracranial pressure (widened pulse pressure, irregular respiration, bradycardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ACTH-producing nonpituitary tumors
Almost always malignant
10% of Cushing syndrome

A

Ectopic ACTH Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Extremely reare
<1% of Cushing syndrome
Bronchial carcinoma most common culprit

A

Ectopic CRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Uncontrolled hypersecretion of cortisol by adrenal tissues

A

ACTH-independent Cushing syndrome

** Adrenal neoplasms and bilateral adrenal disease are in this group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Multiple large (4cm) nodules replacing the glands
Each gland weighs > 60 g
<1% of Cushing syndrome

A

ACTH-independent Macronodular Adrenal Hyperplasia (AIMAH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Normal-sized adrenals
Black or brown cortical nodules
<1% of Cushing syndrome
Autosomal Carney complex (50%): spotty skin and mucous membrane lesions

A

Primary pigmented nodular adrenocortical disease (PPNAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cushing syndrome

A
Central obesity
Moon facies
Buffalo hump
Proximal muscle weakness
Easy bruisability
Abdominal striae

Metabolic syndrome (dyslipidemia, insulin resistance, hypertension

**These are non-specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

___% of patients with Cushing syndrome exhibit ___.

A

50%
Urolithiasis

** Stone formers with cushingoid features also should receive a hypercortisolemia evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hypercortisolemia inbsence of an overt cushingoid phenotype.

A

Autonomous Cortisol Secretion (subclinical Cushing syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain:

Low-dose dexamethasone suppression test

A

Low-dose dexamethasone should act on corticotropic cells of ant. pituitary gland –> suppresses ACTH production –> decreases serum cortisol

Failure to suppress cortisol levels: Cushing syndrome

DOES NOT delineate cause of hypercortisolism and cannot reliably detect subclinical Cushing syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain:
Late night salivary cortisol
Midnight plasma cortisol

A

Cushing syndrome causes disruption of diurnal variation of cortisol levels

Normal: Cortisol peaks in the AM, decreases in the PM
Cushing: Persistent elevation in the PM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

If (+) Cushing syndrome screening:

How do you differentiate between ACTH dependent vs independent?

A

Test for serum ACTH:

Low ACTH: ACTH independent

** The true diagnostic difficulty lies in distinguishing Cushing disease from the ectopic ACTH syndrome for patients who have high serum ACTH levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

If (+) ACTH dependent:

Differentiate ectopic ACTH vs. Cushing disease

A

Direct measurements of ACTH in a downstream venous plexus that drains the pituitary gland—the inferior petrosal sinus—after CRH stimulation has become the gold standard approach for distinguishing ectopic ACTH production from Cushing disease

23
Q

Consequence of bilateral adrenalectomy for refractory hypercorstiolism due to Cushing disease

A

Nelson-Salassa Sydrome

** progressive growth of their pituitary adenoma, mainly resulting in complications such as ocular chiasm compression, oculomotor deficiencies, and, rarely, a rise in intra- cranial pressure

Prophylactic radiation therapy may prevent phenomenon

24
Q

Single best therapeutic approach to normalizing cortisol levels in patients with ectopic ACTH syndrome

A

Resection of the primary ACTH-producing tumor

25
Q

Most common form of secondary hypertension

A

Primary aldosteronism

26
Q

Aldosterone secretion independent of RAAS

Suppressed plasma renin levels

A

Primary aldosteronism

27
Q

Elevated renin levels –> elevated aldosterone secretion

A

Secondary aldosteronism

28
Q

Aldosterone increases sodium ___ and potassium ___ in the distal nephron, BUT does NOT cause hypernatremia (reabsorption is accompanied by water uptake)

A

Na reabsorption

K secretion

29
Q

Causes of Conn syndrome

A
Bilateral adrenal hyperlasia 60%
Adenoma 35%
Unilateral adrenal hyperplasia 2%
Carcinoma <1%
Ectopic aldosterone secreting tumor <1%
Familial hyperaldosteronism <1%
30
Q

Indications for Primary Aldosterone Screening (Box 106.2)

A

Hypertension with hypokalemia
Resistant hypertension (three or more oral agents including a
diuretic)
Controlled hypertension on four or more antihypertensives Adrenal incidentaloma with hypertension
Hypertension with sleep apnea
Early-onset hypertension (<20 years) or stroke (<50 years) Severe hypertension (≥150/≥100) measured on 3 different days Whenever considering secondary causes of hypertension (i.e.,
pheochromocytoma or renovascular disease)
Unexplained hypokalemia (spontaneous or diuretic induced) Evidence of target organ damage disproportionate to degree of
hypertension
Hypertension with family history of primary aldosteronism

31
Q

Screening for primary aldosteronism

A

8AM-10AM
Plasma aldosterone concentration (PAC)
PRA
Direct renin concentration (DRC)

Then calculate aldosterone-renin-ratio (ARR)

32
Q

Confirmatory tests for primary aldosteronism

A

Fludrocortisone suppression test
Oral sodium loading test
IV saline infusion test
Captopril suppression test

33
Q

Fludrocortisone suppression test

A

Fludrocortisone (0.1 mg every 6 hours) + sodium chloride (2 g every 8 hours) x 4 days
After 4 days: PAC is measured in the upright position
** Failure to suppress PAC to less than 6 ng/dL is diagnostic of primary aldosteronism

34
Q

Oral sodium loading test

A

High-sodium diet for 3 days, then 24-hour urine measurements of aldosterone, sodium (at least 12.8 g a day), and creatinine

**Diagnosis of primary aldosteronism is then made when the 24-hour aldosterone is greater than 12 μg/day.

35
Q

Patients with confirmed PA should undergo ___ when adrenalectomy is being considered.

Exceptions: <40 yo, clear unilateral adrenal adenoma, normal contralateral adrenal gland

A

Adrenal vein sampling

36
Q

Medical management for PA who are not surgical candidates

A

Aldosterone receptor antagonists spironolactone and eplerenone are successful in lowering blood pressure and are the antihypertensive agents of choice in patients with primary aldosteronism.

37
Q

Chromaffin bodies in between the aortic bifurcation and the root of the inferior mesenteric artery

A

Organ of Zuckerkandl

** Common site of paragangliomas

38
Q

Components of the 10% tumor (pheochromocytoma)

A
10% extra-adrenal, 
10% familial, 
10% bilateral,
10% pediatric, and 
10% malignant
39
Q

Pheochromocytoma on imaging

A

Well-circumscribed
Rich vascularity, low lipid content
> 10 HU attenuation on unenhanced CT (vs. lipid rich adenomas)
DO NOT exhibit rapid contrast washout on delayed imaging
Classically: light bulb sign (T2 weighted bright signal intensity)

40
Q

Most common alpha-blocker for preoperative catecholamin blockade of pheochromocytoma

A

Phenoxybenzamine

** 7-14 days preop, 10 mg OD, titrated to 10-20 to maintain BP 120-130/80 sitting

41
Q

Life-threatening condition
Preceded by hypotension unresponsive to fluid resuscitation

Acute abdomen, abdominal pain, nausea, vomiting, and fever

A

Acute adrenal insufficiency or adrenal crisis

TX:
Hydrocortisone
Fludrocortisone

42
Q

Hereditary disorders associated with ACC

A

Li-Fraumeni syndrome

Beckwith-Wiedemann syndrome

43
Q

Most common hormone secreted by ACC: ____

Second most common: ___

A

Cortisol (50-80% of functional tumors)

Androgens (40-60% of functional tumors)

44
Q

Imaging characteristics of ACC

A

Larger than benign tumors (avg. size 10-12 cm)
90% of ACC are larger than 5 cm
Irregular borders
Irregular enhancement
Calcifications
Necrotic areas with cystic degeneration
Mean attenuation (39HU) higher than adenomas (8HU)

45
Q

Preferred surgical management for adrenal tumors > 6 cm or those with evidence of local invasion

A

Open adrenalectomy/surgery

** Metastatic: consider cytoreductive removal and debulking metastasectomy IF >90% disease burden can be removed

46
Q

Mitotane MOA

A

Direct cytotoxicity of cells in adrenal cortex
Oxidative damage via free radicals
Inhibition of enzymes involved in steroid synthesis

47
Q

Most valuable imaging study for diagnosis of adrenal adenoma

A

Non-contrast CT: measures density, uniformity, and size

** Attenuation < 10 HU = strongly suggestive of benign adrenal adenoma

48
Q

NIH Consensus: Adrenal lesions > 1cm should undergo ___.

Metabolically active adenomas should undergo: ___

A

Metabolic evaluation

Resection

49
Q

Incidentaloma CT evaluation: request washot films IF: ___

A

> 10 HU on CT or lack of signal dropout on chemical shift MR

50
Q

Absolute and relative percent washout

A

Absolute:
(E - D)/(E-U) x 100

Relative:
(E - D)/(E) x 100

If > 60% absolute and >40% relative –> adenoma

If <60% absolute and <40% relative –> adenoma unlikely

51
Q

The 5-way Test for Adrenal Mass Biopsy

A

Can the mass be characterized with imaging? NO.
Metabolically active? NO.
Will biopsy change management? YES.
ACC strongly suspected? NO.
Benefit of biopsy justify risks inc. making lap adrenalectomy difficult? YES.

If these are your answers, then PERFORM BIOPSY (pheo must be ruled out before doing so).

52
Q

Indications of Surgery/Adrenalectomy

A

• Functional adrenal mass
• Cortisol hypersecretion
• Pheochromocytoma
• Aldosterone hypersecretion
• Mass >4 cm with the exception of myelolipoma (see discussion on size and growth under the Imaging of Adrenal Masses section in text)
• Mass with imaging findings that are suggestive of malignancy (e.g., lipid poor, heterogeneous, irregular borders, infiltrates surrounding structures)
• Adrenal incidentaloma that grows more than 1 cm on follow-up imaging
• Extremely large and/or symptomatic myelolipoma (see discussion on myelolipoma in the Adrenal Lesions section in text)
• Isolated adrenal metastasis (multidisciplinary decision making required)
• During renal surgery for renal cell carcinoma if:
• Adrenal abnormal or not visualized because of large renal
tumor size on imaging
• Vein thrombus to level of adrenal vein
• Failed neurosurgical treatment of Cushing disease, necessitating bilateral adrenalectomy
• Select patients with ectopic adrenocorticotropic hormone (ACTH) syndrome, requiring bilateral adrenalectomy
• ACTH-independent macronodular adrenal hyperplasia (AIMAH)
• Primary pigmented nodular adrenocortical disease (PPNAD)

53
Q

Contraindications to LAP adrenalectomy

A

CONTRAINDICATIONS
Relative
Large tumor
Localized adrenal cortical carcinoma without evidence of local
invasion, adrenal vein, or vena caval involvement or lymph
node metastases (>12 cm)
Morbid obesity
Malignant pheochromocytoma
Virilizing adrenal tumor (70%–80% of these tumors are actually
functional adrenal cortical carcinoma) Significant abdominal adhesion
History of recurrent pyelonephritis Pregnancy
ABSOLUTE
Local recurrence of a previously resected adrenal mass Invasive adrenal cortical carcinoma with evidence of invasion of
neighboring organs or renal vessels or vena caval
involvement
Severe cardiopulmonary disease

54
Q

Oncologic Principles of Resection for ACC

A
  1. No touch technique
  2. Preservation of the intact peritoneum on the anterior surface
    of the adrenal gland if no evidence of invasion through the
    overlying peritoneal layer
  3. En bloc resection of tumor with a wide margin of
    surrounding benign tissue outside the tumor capsule
  4. Strict preservation of an intact tumor capsule
  5. Exclusion of the remainder of the peritoneal cavity as much
    as possible using barriers such as laparotomy pads, plastic
    barriers, or drapes
  6. Minimizing of bleeding and fluid spillage into the peritoneal
    cavity
  7. Extraction of specimen in a bag
  8. Change of gloves, gowns, and instruments after removal of
    the tumor and before closure of the abdomen